Nicholas R. Harrison MPH, MA

Biography

Nicholas leads the Institute's policy research to combat drug-resistant infections and antimicrobial resistance (AMR), primary by researching how policymakers can design well-tailored incentives for the development and stewardship of priority antibiotics and bacterial diagnostics.

Nicholas also contributes health policy and scientific expertise to the Margolis Institute's biomedical innovation and evidence development portfolio. Nicholas has experience engaging collaborative research and convening activities with the U.S. Food and Drug Administration (FDA) to advance regulatory science and the more efficient development of safe and effective drugs and medical products.

Nicholas is broadly interested in the design and implementation of policy that supports the effectiveness and continued evolution of evidence-based practices, with particular interest in medical product and pharmaceutical innovation. Nicholas is a pharmacologist by training and applies broad experience in biomedical science and health policy to evaluate complex challenges and policy ideas and communicate pragmatic policy approaches to stakeholders across the health care landscape, from policymakers and regulators to clinicians and patients.

Websites & Social Links

LinkedIn

Nicholas's ORCID

Nicholas's Twitter